NEW TREATMENT FOR AMD?

This report introduces a study designed to evaluate the safety and efficacy of purified human neural stem cells (HuCNS-SC, StemCells Inc.), as a treatment for dry age-related macular degeneration (AMD). 

Comments

Popular posts from this blog

IMPLANTABLE COLLAMER LENS APPEARS BETTER THAN LASIK OR PRK FOR MODERATE TO HIGH MYOPIC PATIENTS

RINSING YOUR CONTACT LENS CASE IS NOT ENOUGH